证券记录 · 已归档季度
PFE
Pfizer Inc. · Healthcare · Drug Manufacturers - General
24被追踪持有人
-1Δ持有人
1.79B持有股份
$43.32B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -4.0% ·
股份流向 -2.0% ·
净新建仓位 -4.2%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 173 | +3 | 3.03B | $72.98B | +7 | −5 |
| Q1 2026 | 174 | -2 | 3.01B | $84.42B | +3 | −6 |
| Q4 2025 | 175 | 0 | 3.18B | $79.18B | +2 | −1 |
| Q3 2025 | 25 | -1 | 1.84B | $46.80B | +1 | −3 |
| Q2 2025 | 24 | -1 | 1.79B | $43.32B | n/a | −1 |
| Q1 2025 | 22 | +1 | 777.51M | $19.69B | +2 | −1 |
| Q4 2024 | 21 | +2 | 779.18M | $20.66B | +2 | n/a |
| Q3 2024 | 18 | -2 | 507.62M | $14.68B | n/a | −2 |
| Q2 2024 | 20 | n/a | 545.09M | $15.24B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 533.36M | n/a | $12.93B | 0.2% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 494.88M | n/a | $12.00B | 0.2% | n/c | 1 | SEC ↗ ×23 |
| 3 | State Street Global Advisors ✦ (被动) | 296.30M | -0.2% | $7.18B | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 127.47M | +1.4% | $3.08B | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (被动) | 93.65M | +8.8% | $2.27B | 0.3% | ▲ Add | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 77.00M | -25.6% | $1.87B | 0.3% | ▼ Trim | 5 | SEC ↗ ×7 |
| 7 | Fisher Asset Management ✦ | 48.39M | +2.0% | $1.17B | 0.5% | ▲ Add | 5 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 18.72M | +43.4% | $453.75M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 9 | Fidelity (FMR) ✦ | 17.75M | n/a | $430.25M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 10 | Citadel Advisors ✦ | 14.87M | +111.3% | $360.36M | 0.3% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Millennium Management ✦ | 13.99M | +87.6% | $339.20M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 12 | Capital World Investors ✦ | 13.86M | -49.1% | $335.97M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 11.25M | -47.9% | $272.76M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 14 | Starboard Value ✦ | 8.54M | +10.5% | $207.06M | 3.6% | ▲ Add | 3 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 4.96M | +99.1% | $120.24M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 4.30M | -29.2% | $104.21M | 0.1% | ▼ Trim | 5 | SEC ↗ ×8 |
| 17 | D. E. Shaw & Co. ✦ | 3.75M | -37.5% | $90.87M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 18 | Bridgewater Associates ✦ | 1.01M | -38.8% | $24.55M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 904.07K | +110.8% | $21.91M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 20 | GAMCO Investors ✦ | 671.24K | -15.4% | $16.27M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 21 | Fairfax Financial ✦ | 650.90K | 0.0% | $15.77M | 0.8% | Held | 5 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 600.03K | -20.2% | $14.54M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Marshall Wace ✦ | 447.91K | -96.8% | $10.86M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 24 | Dodge & Cox ✦ | 107.96K | -1.6% | $2.62M | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Two Sigma Investments | $18.49M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 225.90K 股份, $6,343 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Aug 12
BOURLA ALBERT
Officer, Director · Chairman & CEO · 38.00K 股 @ 26.34 · $1.00M
公开市场卖出 (S)
在我们的覆盖窗口内无内部人士公开市场卖出记录。
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据